Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection

Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by h...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 9; no. 1; p. 329
Main Authors Hussain, Showket, Bharti, Alok C, Salam, Irfana, Bhat, Mohammad Akbar, Mir, Mohammad Muzaffar, Hedau, Suresh, Siddiqi, Mushtaq A, Basir, Seemi Farhat, Das, Bhudev C
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 16.09.2009
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Differential AP-1 binding activity and expression of its specific proteins between HPV--positive and HPV--negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
AbstractList BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. METHODS: Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. RESULTS: A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. CONCLUSION: Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
Doc number: 329 Abstract Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods: Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results: A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion: Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Differential AP-1 binding activity and expression of its specific proteins between HPV--positive and HPV--negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of esophageal carcinoma is associated with infection of high-risk HPV type 16 and HPV18, the oncogenic expression of which is controlled by host cell transcription factor Activator Protein-1 (AP-1). We, therefore, have investigated the role of DNA binding and expression pattern of AP-1 in esophageal cancer with or without HPV infection. Methods Seventy five histopathologically-confirmed esophageal cancer and an equal number of corresponding adjacent normal tissue biopsies from Kashmir were analyzed for HPV infection, DNA binding activity and expression of AP-1 family of proteins by PCR, gel shift assay and immunoblotting respectively. Results A high DNA binding activity and elevated expression of AP-1 proteins were observed in esophageal cancer, which differed between HPV positive (19%) and HPV negative (81%) carcinomas. While JunB, c-Fos and Fra-1 were the major contributors to AP-1 binding activity in HPV negative cases, Fra-1 was completely absent in HPV16 positive cancers. Comparison of AP-1 family proteins demonstrated high expression of JunD and c-Fos in HPV positive tumors, but interestingly, Fra-1 expression was extremely low or nil in these tumor tissues. Conclusion Differential AP-1 binding activity and expression of its specific proteins between HPV - positive and HPV - negative cases indicate that AP-1 may play an important role during HPV-induced esophageal carcinogenesis.
ArticleNumber 329
Audience Academic
Author Hussain, Showket
Mir, Mohammad Muzaffar
Salam, Irfana
Bhat, Mohammad Akbar
Das, Bhudev C
Hedau, Suresh
Siddiqi, Mushtaq A
Basir, Seemi Farhat
Bharti, Alok C
AuthorAffiliation 2 Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
4 Department of Immunology and Molecular Medicine Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
5 Department of Biosciences, Jamia Millia Islamai; New Delhi, India
6 Dr. B.R. Ambedkar Research Centre for Biomedical Research (ACBR), University of Delhi (North Campus), Delhi, India
1 Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), I-7, Sector-39, Noida, India
3 Department of Cardiovascular and Thoracic Surgery, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
AuthorAffiliation_xml – name: 4 Department of Immunology and Molecular Medicine Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
– name: 5 Department of Biosciences, Jamia Millia Islamai; New Delhi, India
– name: 6 Dr. B.R. Ambedkar Research Centre for Biomedical Research (ACBR), University of Delhi (North Campus), Delhi, India
– name: 2 Department of Clinical Biochemistry, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
– name: 3 Department of Cardiovascular and Thoracic Surgery, Sher-I-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India
– name: 1 Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), I-7, Sector-39, Noida, India
Author_xml – sequence: 1
  givenname: Showket
  surname: Hussain
  fullname: Hussain, Showket
  email: shussain1712@yahoo.co.in
  organization: Division of Molecular Oncology, Institute of Cytology & Preventive Oncology (ICMR), Noida, India. shussain1712@yahoo.co.in
– sequence: 2
  givenname: Alok C
  surname: Bharti
  fullname: Bharti, Alok C
– sequence: 3
  givenname: Irfana
  surname: Salam
  fullname: Salam, Irfana
– sequence: 4
  givenname: Mohammad Akbar
  surname: Bhat
  fullname: Bhat, Mohammad Akbar
– sequence: 5
  givenname: Mohammad Muzaffar
  surname: Mir
  fullname: Mir, Mohammad Muzaffar
– sequence: 6
  givenname: Suresh
  surname: Hedau
  fullname: Hedau, Suresh
– sequence: 7
  givenname: Mushtaq A
  surname: Siddiqi
  fullname: Siddiqi, Mushtaq A
– sequence: 8
  givenname: Seemi Farhat
  surname: Basir
  fullname: Basir, Seemi Farhat
– sequence: 9
  givenname: Bhudev C
  surname: Das
  fullname: Das, Bhudev C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19758438$$D View this record in MEDLINE/PubMed
BookMark eNp1kktr3DAUhU1JaR7tursiuih04UaybMnqIjANfQwEGtp0La4l2aNgSxPJHpIf0f9cOTOkM9CuJHTP-bi6555mR847k2WvCf5ASM3OSclJXpSY5yKnhXiWnTy9HO3dj7PTGG8xJrzG9YvsmAhe1SWtT7LfNwFcVMGuR-sdakGNPqDFdU6QdchEv15BZ6BH8W6CwU8RKdP3SEFQ1vkBPiLoRxNgdsfZkgB2Y8cHBE4jc78OJsaZrKdgXYdW0wAOXcPa9n2yb2yYZltr1Ex4mT1voY_m1e48y359-Xxz-S2_-v51ebm4yhvGqzHXLaGMMUqoaWqNlWgEV7gGpkrFqko3UBjKSKupUYIxXpuKadJWbWtYyQTQs2y55WoPt3Id7ADhQXqw8vHBh05CGK3qjWS6aRXXnJe6KMu2qA3nSpGiotRgWuPEutiy1lMzGK2MGwP0B9DDirMr2fmNLFIGAs-AT1tAY_1_AIcV5Qc5RyvnaKWQKfgEebvrIvi7ycRR3vopuDREKQQVIg2hSKL3W1EH6WfWKe9Gcz92MMUolz9_yEWBBRG4pjxp3-1pV2kFxlX0_fQY9KHwfCtUwccYTPvUOcFyXtJ_9Ppmf2J_9butpH8AIZbm_w
CitedBy_id crossref_primary_10_1007_s13402_011_0056_2
crossref_primary_10_1007_s13277_015_4248_7
crossref_primary_10_1155_2011_263216
crossref_primary_10_3389_fcimb_2020_537650
crossref_primary_10_1002_cam4_884
crossref_primary_10_1038_s41598_018_27699_1
crossref_primary_10_1016_j_oraloncology_2022_106198
crossref_primary_10_1038_s41417_024_00738_y
crossref_primary_10_1111_j_1743_7563_2012_01555_x
crossref_primary_10_1371_journal_pone_0098642
crossref_primary_10_3109_10799893_2011_553836
crossref_primary_10_18632_oncotarget_5832
crossref_primary_10_1007_s11033_019_05123_9
crossref_primary_10_1038_srep07822
crossref_primary_10_3389_fonc_2021_724687
crossref_primary_10_1016_j_semcancer_2021_05_031
crossref_primary_10_1016_j_tice_2022_102010
crossref_primary_10_1016_j_ygyno_2012_11_041
crossref_primary_10_1007_s13277_015_4378_y
crossref_primary_10_1016_j_lfs_2018_02_025
crossref_primary_10_1007_s00005_013_0263_9
crossref_primary_10_18632_oncotarget_26041
crossref_primary_10_2217_fvl_13_116
crossref_primary_10_1038_srep16811
crossref_primary_10_1371_journal_ppat_1005366
crossref_primary_10_3109_00365548_2012_702281
crossref_primary_10_1002_mc_20732
crossref_primary_10_1002_jcb_28716
crossref_primary_10_3109_10799891003786218
Cites_doi 10.1016/j.vaccine.2006.05.111
10.3748/wjg.v10.i4.476
10.1002/ijc.20668
10.1093/carcin/13.11.2179
10.3748/wjg.v12.i25.4033
10.1128/jvi.66.6.3740-3748.1992
10.1038/sj.bjc.6603375
10.1006/geno.1993.1447
10.1016/S0014-4827(03)00346-X
10.1200/JCO.2006.06.1291
10.1016/S0955-0674(97)80068-3
10.1136/jcp.55.10.721
10.1128/jvi.71.1.362-370.1997
10.1002/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F
10.1136/jech.47.4.290
10.1038/ncb0502-e131
10.1007/BF00397910
10.1016/0076-6879(90)82017-V
10.3322/canjclin.55.2.74
10.1038/ng790
10.1016/j.ygyno.2006.01.058
10.1016/j.gassur.2005.09.003
10.1099/0022-1317-73-9-2327
10.1038/35065000
10.1038/sj.onc.1202765
10.1016/0360-3016(94)00419-L
10.1002/(SICI)1097-0215(19990412)81:2<225::AID-IJC10>3.0.CO;2-0
10.1136/gut.33.1.11
10.1074/jbc.M203519200
10.1002/1097-0215(200002)9999:9999<::AID-IJC1095>3.0.CO;2-J
10.1146/annurev.cb.06.110190.002543
10.1016/j.canlet.2004.09.003
10.1158/1541-7786.MCR-06-0311
10.1002/ijc.22262
10.1128/jvi.64.10.4792-4798.1990
10.1016/j.vaccine.2008.03.056
ContentType Journal Article
Copyright COPYRIGHT 2009 BioMed Central Ltd.
2009 Hussain et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2009 Hussain et al; licensee BioMed Central Ltd. 2009 Hussain et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2009 BioMed Central Ltd.
– notice: 2009 Hussain et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2009 Hussain et al; licensee BioMed Central Ltd. 2009 Hussain et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.1186/1471-2407-9-329
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Science In Context
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
AIDS and Cancer Research Abstracts
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList
Publicly Available Content Database

MEDLINE

CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 329
ExternalDocumentID oai_doaj_org_article_6dbfc7d774d244f28e77cc12533e0380
oai_biomedcentral_com_1471_2407_9_329
2631023781
A209190837
10_1186_1471_2407_9_329
19758438
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations India
GeographicLocations_xml – name: India
GroupedDBID ---
-A0
0R~
23N
2VQ
2WC
3V.
4.4
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AAWTL
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C1A
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
IHW
INH
INR
IPNFZ
ISR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
AFGXO
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PQEST
PQUKI
PRINS
ABVAZ
AFNRJ
5PM
ID FETCH-LOGICAL-b675t-df13666313eb8d0c9b97c08a6c4c655dba2e361fd3ec96678e56d1f5ffe6469a3
IEDL.DBID RBZ
ISSN 1471-2407
IngestDate Tue Oct 22 15:15:15 EDT 2024
Tue Sep 17 21:25:22 EDT 2024
Wed May 22 07:11:11 EDT 2024
Thu Oct 10 19:26:57 EDT 2024
Thu Aug 01 19:46:50 EDT 2024
Tue Aug 20 22:01:00 EDT 2024
Thu Sep 12 17:47:24 EDT 2024
Sat Sep 28 07:48:34 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b675t-df13666313eb8d0c9b97c08a6c4c655dba2e361fd3ec96678e56d1f5ffe6469a3
OpenAccessLink http://dx.doi.org/10.1186/1471-2407-9-329
PMID 19758438
PQID 993996782
PQPubID 44074
ParticipantIDs doaj_primary_oai_doaj_org_article_6dbfc7d774d244f28e77cc12533e0380
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2758900
biomedcentral_primary_oai_biomedcentral_com_1471_2407_9_329
proquest_journals_993996782
gale_incontextgauss_ISR_A209190837
gale_healthsolutions_A209190837
crossref_primary_10_1186_1471_2407_9_329
pubmed_primary_19758438
PublicationCentury 2000
PublicationDate 2009-09-16
PublicationDateYYYYMMDD 2009-09-16
PublicationDate_xml – month: 09
  year: 2009
  text: 2009-09-16
  day: 16
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2009
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 17314269 - Mol Cancer Res. 2007 Feb;5(2):109-20
18455843 - Vaccine. 2008 May 23;26(22):2669-79
14966901 - World J Gastroenterol. 2004 Feb 15;10(4):476-80
10188723 - Int J Cancer. 1999 Apr 12;81(2):225-8
16563473 - Gynecol Oncol. 2006 Oct;103(1):100-5
18219112 - Cell Oncol. 2008;30(1):77-87
19653276 - Int J Cancer. 2010 Feb 15;126(4):819-29
2715165 - J Cancer Res Clin Oncol. 1989;115(2):111-7
2168967 - J Virol. 1990 Oct;64(10):4792-8
15514944 - Int J Cancer. 2005 Mar 1;113(6):951-60
12354793 - J Clin Pathol. 2002 Oct;55(10):721-8
15639342 - Cancer Lett. 2005 Jan 31;218(1):69-79
2314237 - Methods Enzymol. 1990;182:194-203
1740265 - Gut. 1992 Jan;33(1):11-5
7713784 - Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1213-36
2125830 - Annu Rev Cell Biol. 1990;6:539-57
1330353 - Carcinogenesis. 1992 Nov;13(11):2179-82
8276409 - Genomics. 1993 Oct;18(1):165
17060942 - Br J Cancer. 2006 Nov 6;95(9):1250-7
8228764 - J Epidemiol Community Health. 1993 Aug;47(4):290-2
16998793 - Int J Cancer. 2006 Dec 15;119(12):2840-50
10359524 - Oncogene. 1999 May 27;18(21):3187-98
16949997 - Vaccine. 2006 Aug 31;24 Suppl 3:S3/11-25
11818961 - Nat Genet. 2002 Feb;30(2):158-66
9133458 - Int J Cancer. 1997 Apr 22;74(2):212-9
16810754 - World J Gastroenterol. 2006 Jul 7;12(25):4033-7
11489794 - Clin Cancer Res. 2001 Aug;7(8):2213-21
14597411 - Exp Cell Res. 2003 Nov 15;291(1):91-100
9069263 - Curr Opin Cell Biol. 1997 Apr;9(2):240-6
15761078 - CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
12082101 - J Biol Chem. 2002 Sep 6;277(36):32668-76
8985358 - J Virol. 1997 Jan;71(1):362-70
11267971 - Int J Cancer. 2001 Mar 1;91(5):625-30
11988758 - Nat Cell Biol. 2002 May;4(5):E131-6
1316480 - J Virol. 1992 Jun;66(6):3740-8
16627221 - J Gastrointest Surg. 2006 Apr;10(4):551-62
1751545 - Biochim Biophys Acta. 1991 Dec 10;1072(2-3):129-57
16763272 - J Clin Oncol. 2006 Jun 10;24(17):2606-11
1328489 - J Gen Virol. 1992 Sep;73 ( Pt 9):2327-36
11242034 - Nature. 2001 Mar 1;410(6824):37-40
DM Parkin (1663_CR1) 2005; 55
T Li (1663_CR30) 2002; 277
KY Lam (1663_CR6) 1997; 74
U Kailash (1663_CR18) 2006; 95
MM Abdel-Latif (1663_CR27) 2006; 10
DM Parkin (1663_CR7) 2006; 24
P Angel (1663_CR24) 1991; 1072
M Karin (1663_CR25) 1997; 9
A Mishra (1663_CR14) 2006; 119
BC Das (1663_CR38) 2008; 26
M Siddiqi (1663_CR2) 1989; 115
I Murtaza (1663_CR5) 2006; 12
R Kumar (1663_CR3) 1992; 13
YC Hu (1663_CR33) 2001; 7
GM Dhar (1663_CR28) 1993; 47
S Katiyar (1663_CR9) 2005; 218
A Mishra (1663_CR37) 2009
MY Wu (1663_CR32) 2004; 10
E Passegue (1663_CR29) 2002; 30
NV Shirsat (1663_CR36) 2003; 291
1663_CR16
BK Prusty (1663_CR21) 2005; 113
L Chang (1663_CR22) 2001; 410
NR Datta (1663_CR41) 2006; 103
BC Das (1663_CR17) 1992; 73
EA Offord (1663_CR10) 1990; 64
U Soto (1663_CR34) 1999; 18
RJ Sinke (1663_CR35) 1993; 18
F Thierry (1663_CR12) 1992; 66
MS Khuroo (1663_CR4) 1992; 33
J de Wilde (1663_CR13) 2008; 30
EM de Villiers (1663_CR39) 1999; 81
C Fakhry (1663_CR40) 2006; 24
KJ Syrjanen (1663_CR8) 2002; 55
JD Dignam (1663_CR19) 1990; 182
CM Robinson (1663_CR31) 2001; 91
F Rosl (1663_CR20) 1997; 71
LJ Ransone (1663_CR23) 1990; 6
MV Karamouzis (1663_CR11) 2007; 5
E Shaulian (1663_CR26) 2002; 4
LR Coia (1663_CR15) 1995; 31
References_xml – volume: 24
  start-page: 11
  issue: Suppl 3
  year: 2006
  ident: 1663_CR7
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2006.05.111
  contributor:
    fullname: DM Parkin
– volume: 10
  start-page: 476
  year: 2004
  ident: 1663_CR32
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v10.i4.476
  contributor:
    fullname: MY Wu
– volume: 113
  start-page: 951
  year: 2005
  ident: 1663_CR21
  publication-title: Int J Cancer
  doi: 10.1002/ijc.20668
  contributor:
    fullname: BK Prusty
– volume: 13
  start-page: 2179
  year: 1992
  ident: 1663_CR3
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/13.11.2179
  contributor:
    fullname: R Kumar
– volume: 12
  start-page: 4033
  year: 2006
  ident: 1663_CR5
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v12.i25.4033
  contributor:
    fullname: I Murtaza
– volume: 66
  start-page: 3740
  year: 1992
  ident: 1663_CR12
  publication-title: J Virol
  doi: 10.1128/jvi.66.6.3740-3748.1992
  contributor:
    fullname: F Thierry
– volume: 95
  start-page: 1250
  year: 2006
  ident: 1663_CR18
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6603375
  contributor:
    fullname: U Kailash
– volume: 18
  start-page: 165
  year: 1993
  ident: 1663_CR35
  publication-title: Genomics
  doi: 10.1006/geno.1993.1447
  contributor:
    fullname: RJ Sinke
– volume: 291
  start-page: 91
  year: 2003
  ident: 1663_CR36
  publication-title: Exp Cell Res
  doi: 10.1016/S0014-4827(03)00346-X
  contributor:
    fullname: NV Shirsat
– volume: 24
  start-page: 2606
  year: 2006
  ident: 1663_CR40
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.06.1291
  contributor:
    fullname: C Fakhry
– volume: 9
  start-page: 240
  year: 1997
  ident: 1663_CR25
  publication-title: Curr Opin Cell Biol
  doi: 10.1016/S0955-0674(97)80068-3
  contributor:
    fullname: M Karin
– volume: 55
  start-page: 721
  year: 2002
  ident: 1663_CR8
  publication-title: J Clin Pathol
  doi: 10.1136/jcp.55.10.721
  contributor:
    fullname: KJ Syrjanen
– volume: 71
  start-page: 362
  year: 1997
  ident: 1663_CR20
  publication-title: J Virol
  doi: 10.1128/jvi.71.1.362-370.1997
  contributor:
    fullname: F Rosl
– volume: 74
  start-page: 212
  year: 1997
  ident: 1663_CR6
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19970422)74:2<212::AID-IJC13>3.0.CO;2-F
  contributor:
    fullname: KY Lam
– volume: 30
  start-page: 77
  year: 2008
  ident: 1663_CR13
  publication-title: Cell Oncol
  contributor:
    fullname: J de Wilde
– volume: 47
  start-page: 290
  year: 1993
  ident: 1663_CR28
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.47.4.290
  contributor:
    fullname: GM Dhar
– volume: 4
  start-page: E131
  year: 2002
  ident: 1663_CR26
  publication-title: Nat Cell Biol
  doi: 10.1038/ncb0502-e131
  contributor:
    fullname: E Shaulian
– volume: 115
  start-page: 111
  year: 1989
  ident: 1663_CR2
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/BF00397910
  contributor:
    fullname: M Siddiqi
– volume: 182
  start-page: 194
  year: 1990
  ident: 1663_CR19
  publication-title: Methods Enzymol
  doi: 10.1016/0076-6879(90)82017-V
  contributor:
    fullname: JD Dignam
– volume: 55
  start-page: 74
  year: 2005
  ident: 1663_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/canjclin.55.2.74
  contributor:
    fullname: DM Parkin
– volume: 30
  start-page: 158
  year: 2002
  ident: 1663_CR29
  publication-title: Nat Genet
  doi: 10.1038/ng790
  contributor:
    fullname: E Passegue
– volume: 103
  start-page: 100
  year: 2006
  ident: 1663_CR41
  publication-title: Gynecol Oncol
  doi: 10.1016/j.ygyno.2006.01.058
  contributor:
    fullname: NR Datta
– volume: 10
  start-page: 551
  year: 2006
  ident: 1663_CR27
  publication-title: J Gastrointest Surg
  doi: 10.1016/j.gassur.2005.09.003
  contributor:
    fullname: MM Abdel-Latif
– volume: 73
  start-page: 2327
  issue: Pt 9
  year: 1992
  ident: 1663_CR17
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-73-9-2327
  contributor:
    fullname: BC Das
– volume: 410
  start-page: 37
  year: 2001
  ident: 1663_CR22
  publication-title: Nature
  doi: 10.1038/35065000
  contributor:
    fullname: L Chang
– ident: 1663_CR16
– volume: 1072
  start-page: 129
  year: 1991
  ident: 1663_CR24
  publication-title: Biochim Biophys Acta
  contributor:
    fullname: P Angel
– volume: 18
  start-page: 3187
  year: 1999
  ident: 1663_CR34
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202765
  contributor:
    fullname: U Soto
– volume: 31
  start-page: 1213
  year: 1995
  ident: 1663_CR15
  publication-title: Int J Radiat Oncol Biol Phys
  doi: 10.1016/0360-3016(94)00419-L
  contributor:
    fullname: LR Coia
– volume: 81
  start-page: 225
  year: 1999
  ident: 1663_CR39
  publication-title: Int J Cancer
  doi: 10.1002/(SICI)1097-0215(19990412)81:2<225::AID-IJC10>3.0.CO;2-0
  contributor:
    fullname: EM de Villiers
– volume: 33
  start-page: 11
  year: 1992
  ident: 1663_CR4
  publication-title: Gut
  doi: 10.1136/gut.33.1.11
  contributor:
    fullname: MS Khuroo
– volume: 277
  start-page: 32668
  year: 2002
  ident: 1663_CR30
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M203519200
  contributor:
    fullname: T Li
– volume: 91
  start-page: 625
  year: 2001
  ident: 1663_CR31
  publication-title: Int J Cancer
  doi: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1095>3.0.CO;2-J
  contributor:
    fullname: CM Robinson
– volume: 7
  start-page: 2213
  year: 2001
  ident: 1663_CR33
  publication-title: Clin Cancer Res
  contributor:
    fullname: YC Hu
– volume-title: Int J Cancer
  year: 2009
  ident: 1663_CR37
  contributor:
    fullname: A Mishra
– volume: 6
  start-page: 539
  year: 1990
  ident: 1663_CR23
  publication-title: Annu Rev Cell Biol
  doi: 10.1146/annurev.cb.06.110190.002543
  contributor:
    fullname: LJ Ransone
– volume: 218
  start-page: 69
  year: 2005
  ident: 1663_CR9
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2004.09.003
  contributor:
    fullname: S Katiyar
– volume: 5
  start-page: 109
  year: 2007
  ident: 1663_CR11
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-06-0311
  contributor:
    fullname: MV Karamouzis
– volume: 119
  start-page: 2840
  year: 2006
  ident: 1663_CR14
  publication-title: Int J Cancer
  doi: 10.1002/ijc.22262
  contributor:
    fullname: A Mishra
– volume: 64
  start-page: 4792
  year: 1990
  ident: 1663_CR10
  publication-title: J Virol
  doi: 10.1128/jvi.64.10.4792-4798.1990
  contributor:
    fullname: EA Offord
– volume: 26
  start-page: 2669
  year: 2008
  ident: 1663_CR38
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2008.03.056
  contributor:
    fullname: BC Das
SSID ssj0017808
Score 2.1201956
Snippet Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial proportion of...
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A...
Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial...
Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (JandK) region of India. A substantial proportion of...
Doc number: 329 Abstract Background: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of...
BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A substantial...
Abstract Background Esophageal squamous cell carcinoma (ESCC) is a leading cause of cancer-related deaths in Jammu and Kashmir (J&K) region of India. A...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 329
SubjectTerms Adult
Aged
Aged, 80 and over
Alphapapillomavirus - physiology
Binding sites
Biomedical research
Cancer therapies
Carcinoma, Squamous Cell - genetics
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - virology
Cervical cancer
Complications and side effects
Deoxyribonucleic acid
DNA
Dysphagia
Esophageal cancer
Esophageal Neoplasms - genetics
Esophageal Neoplasms - metabolism
Esophageal Neoplasms - virology
Female
Gene expression
Gene Expression Regulation, Neoplastic
Genetic aspects
Genetic testing
Human papillomavirus
Humans
India
Male
Middle Aged
Papillomavirus infections
Papillomavirus Infections - genetics
Papillomavirus Infections - metabolism
Papillomavirus Infections - virology
Physiological aspects
Protein Binding
Risk factors
Studies
Surgery
Thoracic surgery
Transcription Factor AP-1 - genetics
Transcription Factor AP-1 - metabolism
Transcription factors
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k0oDwtx4GI1juPYhtOCqApSUQVU6s1ybAdWWtLS3UX8Cf4zM3Z2WasHLlxjTyRnJjPfeF6EvJC9cU0rBatdcFiS0zInuGDKt1FLMPg81VYdf-yOTtsPZ_JsZ9QX5oTl9sD5wx10oR-8CoBSAliiodFRKe_BLAsRa6Gzt16bjTM1xQ-UTrPoOKhejB-oqakP193B9hkzTCCyLArdF4V9Sm38ryrrHWtVZlLumKbDW-TmhCnpLJ_lNrkWxzvk-vEUNb9LfieDtFEPNI_YobMTxul8pBEHGYBWgTcsf6wdXgVQvM6nHscMjeff3Ss6W6TmyyiiSILFEDhzgrox0PhryqUdaa55pCkwQE_cxXyxAPKf88s1kuWsr_EeOT189-XtEZvGMLAevIkVCwMX4OQAB2OvQ-1Nb5Svtet86zspQ--aKDo-BBE9OE9KR9kFPshhiB04307cJ3vj-RgfEur6wSjXAASSGO5se82Vl_3A-SCc4k1FXhfMsBe55YbFJtjlCvyPFllpkZXWWGBlRV5uWLclTD6O7q5ufYOsLd6fHoDo2Un07L9EryLPUDBsrljdqgo7awCEGcC2qiLP0w5stDFiJs9Xt14u7fvPn4pN-xvBspMCWVqAjeCJAnyryIMsYn-PZMDHa4WuiCqErzhMuTLOv6XO4Q1Qmrp-9D9Ov09u5MiaYbx7TPZWl-v4BADaqn-a_sU_t0841w
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: PubMed Central
  dbid: RPM
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJtQHhbiwCXdOI5jB05LRVWQFq2ASr1ZtuO0kbLe7T4q_gT_mbHjlEa9cU08UawZz3zjeSH0nulK5QWjaaZq5UtyilRRQlNuCisYGHwSaqtm38vTs-LbOTvfQ2yohQlJ-0a3R65bHLn2MuRWrhZmMuSJTeaz4xxAbpVlk320DwI6uOgxdMBFJmIPHyLKCQHt60MIPK1SmvdNQoG88AUpoxL3bmSZQgP_u2r6lp0a51DeMkonD9GDiCbxtP_rR2jPusfo3izGy5-gP8EUDYoB98N18HSeEtw6bP0IA9An8IXN1U75SwDsL_Kx8QOG3HKhPuJpF9oue-H0JL4Mwk-bwMrV2P6OWbQO99WOOIQE8Fyt2q4D8ut2vfNkfb6Xe4rOTr78Oj5N4wCGVIMfsU3rhlBwb4B3Vos6M5WuuMmEKk1hSsZqrXJLS9LU1Bpwm7iwrKxJw5rGluB2K_oMHbilsy8QVrqpuMoB_DAf6Cy0INww3RDSUMVJnqBPI2bIVd9sQ_r21-M3cBKl56r0XJWVBK4m6MPAuhvC4N2I8u7Sz561o--HB8v1hYxCJstaN4bXAI1rgD9NLiznxgAWpNRmVGQJeusFQ_a1qjdKQk5zgF8VoFqeoHdhhW-x4XwOz4XabTby688fo0WHg2DJqDo2EgAj-KAA3BL0vBexf1uKkpsgPhK-0WbGb-AIhZ7h8ci8_G_KQ3S_D6RVKSlfoYPtemdfAx7b6jfh_P0FIvc3uw
  priority: 500
  providerName: National Library of Medicine
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k1aHhbiwCVqHCexAwe0IKqCVFQBlfZmObZTVlq8281uxZ_gPzPjeJdalbjGnkTWTGa-8bwIeV13rS6rmueFthpLcqpcc8ZzYSonazD4LNRWnXxtjs-qL9N6GnNzhphWudWJQVHbhcE78kOwowDNwZ69X17kODQKg6txgsZNcouVRYMZXWK687eYkIWM3XyYbA4Z6GEMJoi8zTlCyqTCfZ4YptC__7qWvmKm0hTKKzbp6B65G8EknYzcv09uOP-A3D6J4fKH5E-wRFu9QMfZOnRymjM689ThBANQJ_CG4WKj8Q6A4j0-NThfyC9-6bd0Mg9dl1E2kQSrIHDYBNXeUvc7JtF6OhY70hARoKd6OZvPgfxyttog2Zju5R-Rs6NPPz4e53H-Qt6BG7HObc84eDfAOtdJW5i2a4UppG5MZZq6tp0uHW9Yb7kz4DUJ6erGsr7ue9eA1635Y7LnF949JVR3fSt0Cdinxjhn1UkmTN31jPVcC1Zm5F3CDLUce20o7H6droBQKGSlQlaqVgErM_Jmy7odYXBuZHN96wdkbfL-8GCxOlfxZ1WN7XojLCBjC-inL6UTwhiAgpy7gssiIy9RMNRYqrrTEWpSAvpqAdSKjLwKO7DDhscUnnO9GQb1-fu3ZNPBVrBU1ByD2sl5Rp6MIvbvSC04dxWXGRGJ8CWHSVf87GdoGV4CZVsU-__94gG5M8bK8ILpGdlbrzbuOUCudfci_Fh_AbnYLnM
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Lb9QwELagSIgL4k0oDwtx4BKI4zh2QAgtiKogLaqAlXqzHNspKy3edh-o_Aj-MzNOtlur5brxeJXM6xuPZ4aQF6JtTFkJnhfGGSzJqXLDGc-lrbwS4PBZrK0af633J9WXQ3G4HQc0fMDlpaEdzpOaLGavTk_-vAeFfxcVXtWvGRhYzBLIvMl52Vwl10r4U5zjMK62KQWpCjX09rmEKDYPBexcYaFKUvo-SzxWbOx_0Xyf81_p3cpzzmrvFrk5oEw66sXiNrniwx1yfTzk0e-Sv9FFbQwG7Yfu0NFBzug0UI-jDcDOwA7Lk7XBwwGKB_zU4uChMP9l3tCYZe9P-5AEyyNwCgU1wVF_OtyuDbSvgqRxEiA9MMfT2QzIf08XayTr74GFe2Sy9-nHx_18GMyQtxBfrHLXMQ5hD_DUt8oVtmkbaQtlalvZWgjXmtLzmnWOewvhlFRe1I51out8DeG44ffJTpgH_5BQ03aNNCWAIoEJ0KpVTFrRdox13EhWZuRtwgx93Dfh0NgWO30CGqqRqxq5qhsNXM3Iyw3rzghj1KPqi0s_IGuT_eMP88WRHrRY167trHQAmR3Aoq5UXkprASNy7guuiow8Q8HQfQ3rmfHQoxJgWQNoV2bkeVyBrTcC3u05MuvlUn_-_i1ZtLsRLL3RCA1AEmJTAHQZedCL2PaVBsnNiEyEL3mZ9EmY_oy9xEugbIri0X_33CU3-gRak7P6MdlZLdb-CeCwVfs06tc_l7QxQQ
  priority: 102
  providerName: Scholars Portal
Title Transcription factor AP-1 in esophageal squamous cell carcinoma: alterations in activity and expression during human Papillomavirus infection
URI https://www.ncbi.nlm.nih.gov/pubmed/19758438
https://www.proquest.com/docview/993996782
http://dx.doi.org/10.1186/1471-2407-9-329
https://pubmed.ncbi.nlm.nih.gov/PMC2758900
https://doaj.org/article/6dbfc7d774d244f28e77cc12533e0380
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NbtQwELZoKyEuiH9CIViIA5eIOI5jG067qFVB2mpVqLTiYjmODSstaenuIl6Cd2bGyW6blhuXHBKPJWfGM994PDOEvBa1tkUpeJbbxmJKTplZzngmXemVAIPPYm7V5Lg6Oi0_zcTsslj0tQg-U9VbBuoTYwAy0xkv9A7ZK7CiCjrm46_bgIFUsfncdnBfxecfE1zLbF8MDFKs239TO18xT8Ork1ds0eE9crcHkXTUcf0-ueXbB-T2pA-TPyR_ogXa6APa9dSho2nG6LylHjsXgBqBGZY_1xZ9f4rn99RhX6H27Id9R0eLWG0ZZRJJMPsBm0xQ2zbU_-4vz7a0S3KkMRJAp_Z8vlgA-a_5xRrJumte7SNyenjw5cNR1vddyGpwH1ZZExgHrwZY5mvV5E7XWrpc2cqVrhKiqW3hecVCw70Db0kqL6qGBRGCr8Dbtvwx2W3PWv-UUFsHLW0BmEdgfLOsFZNO1IGxwK1kRULeD5hhzrsaGwarXg-_wAY0yEqDrDTaACsT8mbDui1hdGpUdXPoGFk7mD--AFEz_SY1VVMHJxtAxA2gnlAoL6VzAAE59zlXeUJeomCYLkV1qxvMqADUpQHMyoS8iiOwskaLV3e-2fVyaT5-PhkM2t8Iluk1xtIATgTXE_BaQp50Ina5JA1OXclVQuRA-AaLGX5p599jqfACKHWeP_uv37xP7nQxNJ0V6jnZXV2s_QuAYqs6JTtyJlOyNz44np6k8UADnpNSpXF7pvH07C88ujbK
link.rule.ids 108,230,315,730,783,787,867,888,2109,2228,12068,21400,24330,24949,27936,27937,31731,33756,43322,43817,53804,53806,76140,76141
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdgk4AXxDdhwCzEAy_W4jiJE3hAHdrUwVpVY5P2Zvkro1JJu6ZF_BP8z9wlblk0idfYl8i6y93vfF-EvM9MqZM0EyzWTmNJTsq04IJJm_oiA4PP29qq0TgfXqRfL7PLkJvThLTKjU5sFbWbW7wjPwA7CtAc7NnnxTXDoVEYXA0TNO6SXexUBb7X7uHReHK2DSPIIi5CPx9e5AccNDGGEyQrmUBQ2atxn_VMU9vB_7aevmGo-kmUN6zS8SPyMMBJOuj4_5jc8fUTcm8UAuZPyZ_WFm00A-2m69DBhHE6ranHGQagUOANzfVa4y0AxZt8anHCUD3_qT_Swaztu4zSiSRYB4HjJqiuHfW_QxptTbtyR9rGBOhEL6azGZD_mi7XSNYlfNXPyMXx0fmXIQsTGJgBR2LFXMUF-DfAPG8KF9vSlNLGhc5tavMsc0YnXuS8csJb8Jtk4bPc8SqrKp-D363Fc7JTz2v_klBtqlLqBNBPhpHO1AC_bGYqziuhJU8i8qnHDLXoum0o7H_dXwGxUMhKhaxUpQJWRuTDhnVbwta9KfLbWw-Rtb33tw_myysVfleVO1NZ6QAbO8A_VVJ4Ka0FMCiEj0URR2QfBUN1xapbLaEGCeCvEmCtjMi7dgf22KgxiedKr5tGnXw_623a2wiWCrqjUVtJj8iLTsT-HakE9w5EPSKyJ3y9w_RX6umPtml4ApRlHL_67xf3yf3h-ehUnZ6Mv-2RB13krGQ8f012Vsu1fwMAbGXeht_sLy1YMtc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKkSouqDwbCtRCHLiExnES23DaQlct0GpVqFRxsfwsK7bZ7T4Qf4L_zNjJLhvKjVuUeCw5M575xuOZQehlqYXKi5KmmbIqpOQUqaKEpswUjpdg8EnMrTo5rY7Oiw8X5cUGOlzmwuirMKVx09fr6eejqLPhwXzfn1jfbHVe7RNQrSE-wFKR0lzcQrfBKy9CB4ezg6-rYALjsTHdanBb4ecfE_yV9T7qGKtY0_-m5l4zXd1rlWt2qr-N7rYAE_caibiHNlx9H22dtCH0B-hXtE5LXYGbfju4N0gJHtbYha4GoGJghtn1QoVzARzO9rEJPYfq8ZV6g3ujWIk5yGsgCZkRoQEFVrXF7md7sbbGTQIkjlECPFCT4WgE5D-G00Uga66A1Q_Ref_wy7ujtO3JkGpwLeap9YSCxwPsdJrbzAgtmMm4qkxhqrK0WuWOVsRb6gx4Uoy7srLEl967CjxxRR-hzXpcux2ElfaCqRzwUBlin4XmhJlSe0I8VYzkCXrbYYacNPU3ZKiI3f0C0iEDK2VgpRQSWJmgV0vWrQijw8Orm0MPAms788cX4-mlbDewrKz2hllAyxYQkc-5Y8wYgIeUuozyLEF7QTBkk7660huylwMiEwB0WYJexBGh6kYdrvVcqsVsJo8_n3UG7S4FS7baZCYBQ4JbClguQY8bEfuzJAEOX0F5glhH-DqL6X6ph99iGfEcKEWWPfmv37yHtgbv-_LT8enHXXSnCbWJlFRP0eZ8unDPALHN9fO4H38Dhvo-_Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Transcription+factor+AP-1+in+esophageal+squamous+cell+carcinoma%3A+alterations+in+activity+and+expression+during+human+Papillomavirus+infection&rft.jtitle=BMC+cancer&rft.au=Hussain%2C+Showket&rft.au=Bharti%2C+Alok+C&rft.au=Salam%2C+Irfana&rft.au=Bhat%2C+Mohammad+Akbar&rft.date=2009-09-16&rft.eissn=1471-2407&rft.volume=9&rft.spage=329&rft_id=info:doi/10.1186%2F1471-2407-9-329&rft_id=info%3Apmid%2F19758438&rft.externalDocID=19758438
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon